SMURF2 and prostate adenocarcinoma: Similar to our IHC results, the SMURF2 gene expression analysis conducted on prostate TCGA datasets showed no significant differences in mRNA expression of SMURF2 between normal and PRAD tissues (Figure 3d,e).